Company Overview

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. The company was founded by Dr. Thomas F. Frist, Jr. in 1968 and is headquartered in Nashville, TN. HCA Healthcare operates in the healthcare industry, managing 191 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics across 20 states.

Business Operations & Services

The company operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services. Outpatient services include ambulatory surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

HCA also operates outpatient healthcare facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. Additionally, it operates behavioral hospitals that provide therapeutic programs comprising child, adolescent, and adult psychiatric care, adolescent and adult alcohol and drug abuse treatment, and counseling services.

Market Position & Employee Base

As of September 18, 2025, HCA Healthcare Inc. has 316,000 employees. The company holds a significant market capitalization of $93.45 billion, positioning it as a dominant player in the American healthcare services sector. Its extensive network of hospitals and healthcare facilities across 20 states solidifies its leading position.

Financial Performance

Q2 2025 Results (June 30, 2025)

Key second quarter metrics show revenues increased 6.4% to $18.605 billion. Net income attributable to HCA Healthcare, Inc. increased 13.1% to $1.653 billion, and diluted earnings per share increased 23.5% to $6.83 per diluted share.

Q1 2025 Results (March 31, 2025)

First quarter revenues totaled $18.321 billion. Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share.

FY 2024 Results

In 2024, HCA Healthcare's revenue was $70.60 billion, an increase of 8.67% compared to the previous year's $64.97 billion. Earnings were $5.76 billion, an increase of 9.88%.

FY 2025 Guidance Update

For FY 2025, the company expects adjusted EBITDA of between $14.70 billion – $15.30 billion, an increase from the prior guidance of $14.30 billion – $15.10 billion.

Key Financial Metrics

- Q2 2025 Revenue: $18.605 billion (up 6.4%)

- Q2 2025 Net Income: $1.653 billion (up 13.1%)

- Q2 2025 Diluted EPS: $6.83 (up 23.5%)

- FY 2024 Revenue: $70.60 billion

- FY 2024 Earnings: $5.76 billion

- FY 2025 Guidance (Adj. EBITDA): $14.70 billion – $15.30 billion

- EBITDA (Current): $14.50 billion USD

- EBITDA Margin: 19.63%

- Dividend Yield (2024): 0.88%

- Dividend Payout Ratio (2024): 12.00%

- Dividend Declared: $0.72 per share

- Share Repurchases: 7.031 million shares repurchased; $5.753 billion remaining authorization as of June 30, 2025

Stock Performance

HCA reached its all-time high on September 5, 2025, with the price of $420.98 USD. HCA stock has fallen by -0.12% compared to the previous week, but the month change shows a 0.26% rise. Over the last year, HCA Healthcare Inc. has shown a 0.78% increase.

Investment Characteristics

HCA stock exhibits relatively low volatility, with a stock price volatility of 2.98% and a beta coefficient of 0.29, indicating lower risk compared to the broader market. The company trades on the New York Stock Exchange under the ticker symbol HCA.

HCA Healthcare Inc. is scheduled to release its next earnings report on October 17, 2025, providing investors with the next key milestone for financial performance updates.

Industry Position

HCA Healthcare stands as one of the nation's leading healthcare providers. Its extensive network of hospitals and healthcare facilities positions it as a dominant player in the American healthcare services sector. The company's diversified healthcare portfolio spans acute care, outpatient services, and specialized treatments, providing comprehensive healthcare solutions across its operating markets.